Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

School of Medicine boasts with a new unit
2013-02-22

 

New Clinical Skills Simulation unit is one of its kind.
Photo: Supplied
22 February 2013


The Faculty of Health Sciences at the University of the Free State (UFS) can now boasts with a new Medical Clinical Skills Simulation unit (MCSU) at the School of Medicine.

This newly established Clinical Simulation Unit is the first dedicated clinical simulation unit of its kind in South Africa. It was opened on Thursday 21 February 2013.

This facility is equipped with an operating theatre, Intensive Care Unit, two simulation and three private rooms.

In addition, the Unit has control rooms with cameras for recording purposes and debriefing facilities, the latter with video equipment for playback of recorded scenarios.

The Simulation Unit at the UFS’ School of Medicine is based on accredited units in the USA and the UK.

Dr Mathys Labuschagne, Head of the Simulation Unit, says the concept for this kind of unit is still new, but is already a very important part of clinical skills training in the health professions.

“We are the only university in South Africa with a unit dedicated to clinical skills simulation only and not a combination of clinical skills training which includes some simulation.”

The primary goal of the MCSU is to provide educational opportunities to undergraduate and postgraduate medical students, as well as opportunities for other healthcare students in the Faculty of Health Sciences, to be exposed to inter-professional skills training. The MCSU will play a role in quality assurance of training and assessment, as well as research.

The aim of the Clinical Simulation Unit is to provide a facility where medical and other healthcare students or professionals can be exposed to:

  • Training in a safe environment.
  • Training without harm to the patient.
  • Scenario-based learning.
  • Debriefing.

The facility will also be utilised for post-qualification refresher and training courses.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept